Jalyn and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Jalyn (dutasteride; tamsulosin hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Prostatic disorder.

The phase IV clinical study analyzes which people have Weakness when taking Jalyn. It is created by eHealthMe based on reports of 1,123 people who have side effects when taking Jalyn from the FDA, and is updated regularly.

What is Jalyn?

Jalyn has active ingredients of dutasteride; tamsulosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 1,168 Jalyn users. Check the latest studies of Jalyn.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 16, 2026

1,123 people reported to have side effects when taking Jalyn.
Among them, 36 people (3.21%) have Weakness.

Among these 36 people:

How long have people been on Jalyn when they have Weakness? *

What is the gender of people who have Weakness when taking Jalyn? *

female: 2.86 %
male: 97.14 %

What is the age of people who have Weakness when taking Jalyn? *

What are other drugs people take besides Jalyn? *

What are other side effects people have besides Weakness? *

Hypotension (abnormally low blood pressure): 10 people, 27.78%
Dyspnea (difficult or laboured breathing): 10 people, 27.78%
Weight Decreased: 8 people, 22.22%
Diarrhea: 7 people, 19.44%
Fatigue (feeling of tiredness): 7 people, 19.44%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 16.67%
Nasopharyngitis (inflammation of the nasopharynx): 5 people, 13.89%
Dizziness: 5 people, 13.89%
Hypersensitivity: 4 people, 11.11%
Chest Pain: 4 people, 11.11%

What are the existing conditions these people have? *

Prostatic Disorder: 5 people, 13.89%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 4 people, 11.11%
High Blood Pressure: 4 people, 11.11%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 8.33%
Prostate Cancer Metastatic: 3 people, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 8.33%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 5.56%
Thyroid Diseases: 2 people, 5.56%
Renal Cell Carcinoma (a kidney cancer): 2 people, 5.56%
High Blood Cholesterol: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Jalyn and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Jalyn:

Jalyn (1,168 reports)

Weakness treatments and more:

Weakness (586,876 reports)

How severe was Weakness and when was it recovered:

Weakness in Jalyn

Expand to all the drugs that have ingredients of dutasteride; tamsulosin hydrochloride:

Weakness and drugs with ingredients of dutasteride; tamsulosin hydrochloride (45 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Jalyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,639 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,612 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dutasteride; tamsulosin hydrochloride (the active ingredients of Jalyn) and Jalyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.